5//SEC Filing
Danziger Asaf 5
Accession 0001654435-26-000001
CIK 0001645113other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:21 PM ET
Size
5.6 KB
Accession
0001654435-26-000001
Insider Transaction Report
Form 5
NovoCure LtdNVCR
Danziger Asaf
Director
Transactions
- Award
Ordinary Shares
2025-12-31$10.99/sh+1$11→ 416,474 total
Footnotes (2)
- [F1]The reporting person is reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2025.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001654435
Filing Metadata
- Form type
- 5
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:21 PM ET
- Size
- 5.6 KB